Cytosorbents (CTSO) Non Operating Income (2010 - 2026)
Cytosorbents' (CTSO) quarterly Non Operating Income came in at -$2.1 million in Q1 2026, down 244.63% YoY from $1.4 million in Q1 2025, and down 126.01% on a QoQ basis from $8.0 million in Q4 2025.
Cytosorbents (CTSO) Non Operating Income (2010 - 2026) Analysis & Trends
Cytosorbents (CTSO) has 17 years of Non Operating Income data on file, last reported at -$2.1 million in Q1 2026.
- Quarterly Non Operating Income fell 244.63% year-over-year to -$2.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.7 million (up 274.45% YoY) and the FY2025 annual result came in at $6.1 million, up 539.6% from the prior year.
- Non Operating Income eased to -$2.1 million in Q1 2026, from $8.0 million in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $8.0 million in Q4 2025 to a low of -$3.2 million in Q3 2022.
- A 5-year average of $301237.4 and a median of -$588000.0 in 2024 frame the typical range for Non Operating Income.
- Annual changes were most pronounced in 2022 — Non Operating Income tumbled 19394.46% — and 2025, when it jumped 714.72%.
- Tracing CTSO's Non Operating Income over 5 years: stood at $7.0 million in 2022, then slumped by 61.61% to $2.7 million in 2023, then plunged by 148.43% to -$1.3 million in 2024, then jumped by 714.72% to $8.0 million in 2025, then sank by 126.01% to -$2.1 million in 2026.
- The last three Non Operating Income figures came in at -$2.1 million (Q1 2026), $8.0 million (Q4 2025), and -$645000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 46.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 6.60 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | - |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | -12.30 Mn |
| 10 | Cytosorbents | 19.47 Mn | 15.06 Mn | 7.05 Mn | -1.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.78 Mn |
| Mar 31, 2026 | -2.09 Mn |
| Dec 31, 2025 | 8.02 Mn |
| Sep 30, 2025 | -645,000.00 |
| Jun 30, 2025 | -616,000.00 |
| Mar 31, 2025 | -605,000.00 |
| Dec 31, 2024 | -1.30 Mn |
| Sep 30, 2024 | -588,000.00 |
| Jun 30, 2024 | -180,000.00 |
| Mar 31, 2024 | -6,653.00 |
| Dec 31, 2023 | 2.69 Mn |
| Sep 30, 2023 | -33,670.00 |
| Jun 30, 2023 | 406,153.00 |
| Mar 31, 2023 | -63,170.00 |
| Dec 31, 2022 | 7.01 Mn |
| Sep 30, 2022 | -3.18 Mn |
| Jun 30, 2022 | -2.52 Mn |
| Mar 31, 2022 | -1.18 Mn |
| Dec 31, 2021 | 2.10 Mn |
| Sep 30, 2021 | -1.00 Mn |